Pharmaceutical Industry Information Portal

HomeTagsVaccines

All posts by tag

Vaccines

GDP combined with new technology and infrastructure, will help ensure global integrity

Governments around the world struggle with the logistical challenges of procuring, deploying and administering vaccines at scale. To deliver the vaccines, pharmaceutical companies, logistical partners...

NANOLEK will invest 5 billion rubles in the full production cycle

Nanolek, a biopharmaceutical company, announces a plan to invest 5 billion rubles over 3 years in its full-cycle vaccine production facility in the Kirov region and an R&D Center for Biotech Medicines in Moscow.

EU Approval of Russia’s Sputnik V Vaccine Delayed – Reuters

European Union approval of Russia’s Sputnik V coronavirus vaccine will be delayed because a June 10 deadline to submit data was missed, two people...

Novavax Covid-19 Vaccine demonstrates 90,4% Effective in Late-stage Trial

Biotech company Novavax said that its COVID-19 vaccine is 90.4% effective in a late-stage trial of nearly 30,000 people in the U.S. and Mexico

Global Biopharmaceutical Industry is on track to produce at least 10 billion doses of COVID-19 vaccine by end 2021

Biopharmaceutical industry welcomes COVID-19 vaccine-sharing pledges but warn challenges remain to urgently address vaccine inequity

The plant of Nanolek is about to launch production of the third Covivac vaccine

Nanolek uses a traditional technology to produce this vaccine containing an inactivated virus that triggers a potent immune response.
spot_img

Expert Articles

spot_img